Showing 91-100 of 6901 results for "".
- What Your Patients Are Talking About - Programshttps://reachmd.com/programs/what-your-patients-are-talking-about/
- FCDC Action Center - Programshttps://reachmd.com/programs/fcdc-action-center/
- Your Money, Your Life: Financial Advice for Physicians - Programshttps://reachmd.com/programs/your-money-your-life-financial-advice-for-physicians/
- Immuno-Oncology (IO) Updates - Programshttps://reachmd.com/programs/immuno-oncology-io-updates/Keep up-to-date on the latest management options for all cancer types, including: non-small cell lung cancer, head and neck, and more! This series provides an overview of efficacy and safety of strategies targeting the immune system, including the use of immune-modifying agents, and immune checkpoi…
FCS: Enhancing the Diagnosis
https://reachmd.com/programs/cme/fcs-enhancing-the-diagnosis/33220/Listen to experts discussing the latest developments in APOC3 inhibition for the treatment of patients with FCS, SHTG, and mixed hyperlipidemia.The Road Ahead: What's on the Horizon for FCS and SHTG Management
https://reachmd.com/programs/cme/the-road-ahead-whats-on-the-horizon-for-fcs-and-shtg-management/33228/Listen to experts discussing the latest developments in APOC3 inhibition for the treatment of patients with FCS, SHTG, and mixed hyperlipidemia.Latest Clinical Trial Outcomes and Breakthroughs for FCS
https://reachmd.com/programs/cme/latest-clinical-trial-outcomes-and-breakthroughs-for-fcs/33223/Listen to experts discussing the latest developments in APOC3 inhibition for the treatment of patients with FCS, SHTG, and mixed hyperlipidemia.Is the Y Chromosome Disappearing?
https://reachmd.com/programs/what-your-patients-are-talking-about/y-chromosome-disappearing/7391/Researchers at Penn State University say there is a dramatic loss of genes from the human Y chromosome, and that it could eventually lead to its complete disappearance in the distant future.APOC3 Inhibition: New Frontiers Managing Patients with FCS & SHTG
https://reachmd.com/programs/cme/apoc3-inhibition-new-frontiers-managing-patients-with-fcs-shtg/20307/Listen to experts discussing the latest developments in APOC3 inhibition for the treatment of patients with FCS, SHTG, and mixed hyperlipidemia.Policy Agenda for Y-ME National Breast Cancer Org.
https://reachmd.com/programs/clinicians-roundtable/policy-agenda-for-y-me-national-breast-cancer-org/1932/Director of Government Relations for the Y-ME Breast Cancer Organization, Kay Wissmann, joins host Dr. Larry Kaskel to discuss the past, future and current efforts of the Y-ME and other breast cancer organizations to improve research, awareness and funding for the cure for breast cancer.